Viking Therapeutics, Inc. - COMMON STOCK (VKTX)

Historical Holders from Q2 2015 to Q3 2025

Symbol
VKTX on Nasdaq
CUSIP
92686J106
Type / Class
Equity / COMMON STOCK
Shares outstanding
113M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
71.2M
Holdings value
$1.87B
% of all portfolios
0.004%
Grand Portfolio weight change
0%
Number of holders
359
Number of buys
186
Number of sells
-171
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Viking Therapeutics, Inc. - COMMON STOCK (VKTX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 5.1% -40% $152M -$105M 5.77M -40.9% FMR LLC Sep 30, 2025
BlackRock, Inc. 4.5% -16% $141M -$23.5M 5.03M -14.3% BlackRock, Inc. Mar 31, 2025

Institutional Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 71.2M $1.87B -$130M $26.28 359
2025 Q2 76.2M $2.02B +$15.6M $26.50 386
2025 Q1 76.2M $1.84B -$233M $24.15 365
2024 Q4 82M $3.3B -$87.5M $40.24 405
2024 Q3 81.6M $5.17B +$153M $63.31 427
2024 Q2 80.3M $4.26B -$165M $53.01 389
2024 Q1 79.8M $6.54B +$360M $82.00 371
2023 Q4 76.3M $1.42B +$16.9M $18.61 196
2023 Q3 77.1M $853M +$8.95M $11.07 181
2023 Q2 74.8M $1.21B +$127M $16.21 196
2023 Q1 66.5M $1.11B +$548M $16.65 184
2022 Q4 34M $320M +$76.4M $9.40 129
2022 Q3 26.6M $72.3M -$1.01M $2.72 95
2022 Q2 26.7M $77.2M -$11.6M $2.89 98
2022 Q1 31M $93.2M -$16.6M $3.00 132
2021 Q4 36.2M $166M -$8.9M $4.60 133
2021 Q3 37.8M $238M -$338K $6.28 125
2021 Q2 37.9M $227M -$19.6M $5.99 135
2021 Q1 41M $259M +$21M $6.32 139
2020 Q4 37.7M $213M -$11.1M $5.63 138
2020 Q3 39.6M $230M -$4.36M $5.82 142
2020 Q2 40.2M $290M +$8.15M $7.21 137
2020 Q1 39.4M $184M -$8.37M $4.68 133
2019 Q4 39.8M $319M -$5.27M $8.02 138
2019 Q3 40.7M $280M -$33.4M $6.88 141
2019 Q2 45.1M $374M -$7.34M $8.30 152
2019 Q1 45.7M $454M -$4.97M $9.94 161
2018 Q4 46.9M $359M -$11.2M $7.65 160
2018 Q3 43.2M $753M +$281M $17.42 150
2018 Q2 31.6M $300M +$126M $9.49 117
2018 Q1 20.9M $91.4M +$50.6M $4.37 62
2017 Q4 9.33M $37.9M +$30.1M $4.06 32
2017 Q3 2.02M $3.85M +$1.49M $1.91 16
2017 Q2 1.57M $1.69M +$856K $1.08 11
2017 Q1 770K $1.12M +$227K $1.46 10
2016 Q4 636K $757K -$869K $1.19 11
2016 Q3 1.21M $1.7M +$496K $1.41 13
2016 Q2 860K $1.08M +$1.03M $1.26 12
2016 Q1 44.4K $65K -$26K $1.53 6
2015 Q4 41.3K $140K -$14.6K $3.36 5
2015 Q3 43.2K $252K -$77.6K $5.83 6
2015 Q2 54K $384K +$384K $7.10 5